Mankind Pharma Limited (BOM:543904)

Market Cap	850.58B -16.0%
Revenue (ttm)	139.14B +19.5%
Net Income	17.79B -12.8%
EPS	43.10 -15.2%
Shares Out	n/a
PE Ratio	47.80
Forward PE	36.51
Dividend	1.00 (0.05%)
Ex-Dividend Date	Aug 8, 2025

Volume	4,948
Average Volume	22,091
Open	2,078.85
Previous Close	2,078.90
Day's Range	2,049.75 - 2,085.35
52-Week Range	2,029.35 - 2,726.75
Beta	n/a
RSI	41.88
Earnings Date	Feb 3, 2026

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 19,620
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543904

Financial Performance

In fiscal year 2025, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.